Virtus ETF Advisers LLC Dice Therapeutics, Inc. Transaction History

Virtus ETF Advisers LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$25.86 - $46.71 $4,809 - $8,688	186 Added 6.24%	3,166 $147,000
Q1 2023 May 15, 2023	SELL	$26.05 - $32.31 $29,879 - $37,059	-1,147 Reduced 27.79%	2,980 $85,000
Q4 2022 Feb 14, 2023	SELL	$19.77 - $42.23 $67,475 - $144,130	-3,413 Reduced 45.27%	4,127 $128,000
Q3 2022 Nov 14, 2022	BUY	$14.97 - $22.65 $868 - $1,313	58 Added 0.78%	7,540 $153,000
Q2 2022 Aug 12, 2022	BUY	$13.19 - $22.1 $15,379 - $25,768	1,166 Added 18.46%	7,482 $116,000
Q1 2022 May 16, 2022	SELL	$14.54 - $25.02 $5,336 - $9,182	-367 Reduced 5.49%	6,316 $121,000
Q4 2021 Feb 14, 2022	BUY	$22.41 - $37.54 $149,766 - $250,879	6,683 New	6,683 $169,000

17.7K

13K

Ticker DICE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,430,000
Description
DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Virtus ETF Advisers LLC with notifications on news.